The Joshua W. Lavender Foundation’s mission is to find new and significant treatments, delivering a significant result in the treatment of HIV/AIDS, Hepatitis C and Pediatric Malaria. It’s Chair, Mr. Ronald Rice, having personally experienced multiple losses over the years of friends and family, who had been infected by HIV and passed due to complications from AIDS, fuels the Foundation’s passion for change.

Lavender Foundation is determined to assist others in lessening the pain and agony infection of these diseases bring to the patient and to the family, friends and loved ones who suffer the challenges of prolonged disability and the ultimate loss that are so characteristic of HIV/AIDS and Hepatitis C.

At this time, a truly effective, non-toxic, non-liver damaging, long-term treatment for HIV/AIDS has not been delivered to the world’s HIV/AIDS and Hepatitis C infected population. Further, due to the lack of meaningful education, on a global scale, on sexually/lifestyle transmitted disease we have not seen any dramatic reductions in rates of infection. Additionally, much of the developed world is under the assumption that the medications now available are the answer to the challenge of HIV/AIDS and Hepatitis C; clearly they are not.

The team at Lavender began a search many years ago, that has taken them to many people and places around the world. Their search was for a improved and meaningful treatment that would deliver an improvement in quality of life for those diagnosed and infected with HIV/AIDS and Hepatitis C. Years of leads, setbacks, and dead ends, lead them to a world renowned Biochemist and his Research Group, in Eastern Europe and a new set of formulations we will call “compounds”.

These compounds are a pharmaceutical product originally derived as a plant extract. To date, they have, anecdotally, proven significant efficacy to reduce the challenges of HIV/AIDS and Hepatitis C individually and in co-infection. The compounds can be administered as a stand alone treatment for AIDS related Hepatitis C and they also appear to work in harmony with other HIV/AIDS Antiretroviral (ARV) medications currently in general use in the world. In fact a recent case demonstrated substantial health improvements for a patient on contemporary ARV medications due to its excellent hepatic (liver) support aiding in improved liver function. Further rigorous scientific studies are underway and the data developed as the Foundation progresses to the funding of its initial set of clinical trials in the near future will be reported here on our site.